Arete Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-577
Closed -$269K 485
2025
Q4
$269K Buy
+577
New +$268K 0.02% 625
2023
Q3
Sell
-811
Closed -$246K 594
2023
Q2
$246K Sell
811
-1,079
-57% -$300K 0.02% 545
2023
Q1
$498K Buy
1,890
+601
+47% +$153K 0.04% 344
2022
Q4
$309M Buy
1,289
+25
+2% +$5.6K 0.03% 451
2022
Q3
$232K Buy
1,264
+24
+2% +$4.78K 0.02% 484
2022
Q2
$208K Hold
1,240
0.02% 423
2022
Q1
$311K Hold
1,240
0.03% 369
2021
Q4
$315K Hold
1,240
0.03% 375
2021
Q3
$301K Hold
1,240
0.03% 327
2021
Q2
$236K Buy
+1,240
New +$253K 0.03% 304

Other funds holding HCA

Arete Wealth Advisors's HCA Position: Q1 2026 in Review

Arete Wealth Advisors sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 577 shares — an estimated $269K sold.

Arete Wealth Advisors first reported a position in HCA in Q2 2021 and held it in 10 quarters. The position peaked at $309M in Q4 2022. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Arete Wealth Advisors reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 577 HCA Healthcare shares in Q1 2026, an estimated $269K.
  • Arete Wealth Advisors first reported a position in HCA Healthcare in Q2 2021 and held it in 10 quarters.
  • Arete Wealth Advisors's HCA Healthcare position peaked at $309M in Q4 2022.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.